05/25/2026
Skin cancer is one of the most common cancers worldwide, and cases are rising. At ICRF, researchers like Prof. Emily Avitan-Hersh are working to change that 👇
Prof. Avitan-Hersh is the Director of Dermatology and Head of the Melanoma Surveillance Program at Rambam Health Care Campus - Hospital in Israel. Through the Daisy Ge**er Memorial Project Grant, she is investigating a key receptor called CXCR7 and how it affects tumor growth and the immune system's ability to fight skin cancer. Her goal: to improve the effectiveness of immunotherapy for patients with advanced squamous cell carcinoma, one of the most aggressive forms of skin cancer.
This is what the answer to cancer looks like.